Olanzapine (Zyprexa) is approved to treat schizophrenia in adults and children ages 13 years and older, manic and mixed episodes related to bipolar I disorder in adults and children ages 13 years and ...
Zyprexa addition to standard antiemetics significantly reduces RINV incidence and severity in abdominal/pelvic radiotherapy patients. The trial showed marked improvements in nausea, vomiting, anxiety, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results